The DOI matches its Crossref record; 140 of the 140 references it cites were found in a registry or an index.
Epidermal Growth Factor Receptor in Glioma: Signal Transduction, Neuropathology, Imaging, and Radioresistance
Open accessAbstract
Aberrant epidermal growth factor receptor (EGFR) signaling is common in cancer. Increased expression of wild type and mutant EGFR is a widespread feature of diverse types of cancer. EGFR signaling in cancer has been the focus of intense investigation for decades primarily for two reasons. First, aberrant EGFR signaling is likely to play an important role in the pathogenesis of cancer, and therefore, the mechanisms of EGFR-mediated oncogenic signaling are of interest. Second, the EGFR signaling system is an attractive target for therapeutic intervention. EGFR gene amplification and overexpression are a particularly striking feature of glioblastoma (GBM), observed in approximately 40% of tumors. GBM is the most common primary malignant tumor of the central nervous system in adults. In approximately 50% of tumors with EGFR amplification, a specific EGFR mutant (EGFRvIII, also known as EGFR type III, de2-7, Delta EGFR) can be detected. This mutant is highly oncogenic and is generated from a deletion of exons 2 to 7 of the EGFR gene, which results in an in-frame deletion of 267 amino acids from the extracellular domain of the receptor. EGFRvIII is unable to bind ligand, and it signals constitutively. Although EGFRvIII has the same signaling domain as the wild type receptor, it seems to generate a distinct set of downstream signals that may contribute to an increased tumorigenicity. In this review, we discuss recent progress in key aspects of EGFR signaling in GBM, focusing on neuropathology, signal transduction, imaging of the EGFR, and the role of the EGFR in mediating resistance to radiation therapy in GBM.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Duxbury, M. S., Ito, H., Zinner, M. J., Ashley, S. W., & Whang, E. E. (2004) · Oncogene · doi:10.1038/sj.onc.1207247 · Cited by 211
RetractedThe 2007 WHO Classification of Tumours of the Central Nervous System
Louis, D. N., Ohgaki, H., Wiestler, O. D., Cavenee, W. K., Burger, P. C., Jouvet, A., Scheithauer, B. W., & Kleihues, P. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0243-4 · Cited by 15,397
Lynch, T. J., Bell, D. W., Sordella, R., Gurubhagavatula, S., Okimoto, R. A., Brannigan, B. W., Harris, P. L., Haserlat, S. M., Supko, J. G., Haluska, F. G., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040938 · Cited by 11,486 · cited 1×
“[23] Lynch TJ, Bell DW, Sordella R, Gurubhagavatula S, Okimoto RA, Brannigan BW, Harris PL, Haserlat SM, Supko JG, Haluska FG, et al.”
BackgroundEGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
Paez, J. G., Jänne, P. A., Lee, J. C., Tracy, S., Greulich, H., Gabriel, S., Herman, P., Kaye, F. J., Lindeman, N., Boggon, T. J., et al. (2004) · Science · doi:10.1126/science.1099314 · Cited by 9,368
Screening for Epidermal Growth Factor Receptor Mutations in Lung Cancer
Rosell, R., Moran, T., Queralt, C., Porta, R., Cardenal, F., Camps, C., Majem, M., Lopez-Vivanco, G., Isla, D., Provencio, M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0904554 · Cited by 2,373
Aaronson, S. A. (1991) · Science · doi:10.1126/science.1659742 · Cited by 2,028
Batchelor, T. T., Sorensen, A. G., di Tomaso, E., Zhang, W.-T., Duda, D. G., Cohen, K. S., Kozak, K. R., Cahill, D. P., Chen, P.-J., Zhu, M., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.11.021 · Cited by 1,769
Carpenter, G., & Cohen, S. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)38983-5 · Cited by 1,622
Genetic Pathways to Primary and Secondary Glioblastoma
Ohgaki, H., & Kleihues, P. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.070011 · Cited by 1,497
Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors
Mellinghoff, I. K., Wang, M. Y., Vivanco, I., Haas-Kogan, D. A., Zhu, S., Dia, E. Q., Lu, K. V., Yoshimoto, K., Huang, J. H. Y., Chute, D. J., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051918 · Cited by 1,442
Autocrine Secretion and Malignant Transformation of Cells
Sporn, M. B., & Todaro, G. J. (1980) · New England Journal of Medicine · doi:10.1056/nejm198010093031511 · Cited by 1,346
The EGF receptor family as targets for cancer therapy
Mendelsohn, J., & Baselga, J. (2000) · Oncogene · doi:10.1038/sj.onc.1204082 · Cited by 1,340
Perturbations of the AKT signaling pathway in human cancer
Altomare, D. A., & Testa, J. R. (2005) · Oncogene · doi:10.1038/sj.onc.1209085 · Cited by 1,329
Ang, K. K., Berkey, B. A., Tu, X., Zhang, H. Z., Katz, R. L., Hammond, E. H., Fu, K. K., & Milas, L. (2002) · PubMed · Cited by 1,198
A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity.
Nishikawa, R., Ji, X. D., Harmon, R. C., Lazar, C. S., Gill, G. N., Cavenee, W. K., & Huang, H. J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.16.7727 · Cited by 936
Long-term survival with glioblastoma multiforme
Krex, D., Klink, B., Hartmann, C., von Deimling, A., Pietsch, T., Simon, M., Sabel, M., Steinbach, J. P., Heese, O., Reifenberger, G., et al. (2007) · Brain · doi:10.1093/brain/awm204 · Cited by 887
Structural alterations of the epidermal growth factor receptor gene in human gliomas.
Wong, A. J., Ruppert, J. M., Bigner, S. H., Grzeschik, C. H., Humphrey, P. A., Bigner, D. S., & Vogelstein, B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.7.2965 · Cited by 853
Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis
Sparmann, A., & Bar-Sagi, D. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.09.028 · Cited by 851
The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis
Brat, D. J., Bellail, A. C., & Van Meir, E. G. (2005) · Neuro-Oncology · doi:10.1215/s1152851704001061 · Cited by 760
Watanabe, K., Tachibana, O., Sato, K., Yonekawa, Y., Kleihues, P., & Ohgaki, H. (1996) · Brain Pathology · doi:10.1111/j.1750-3639.1996.tb00848.x · Cited by 740
Ekstrand, A. J., James, C. D., Cavenee, W. K., Seliger, B., Pettersson, R. F., & Collins, V. P. (1991) · PubMed · Cited by 719
Mammalian Expression of Infrared Fluorescent Proteins Engineered from a Bacterial Phytochrome
Shu, X., Royant, A., Lin, M. Z., Aguilera, T. A., Lev-Ram, V., Steinbach, P. A., & Tsien, R. Y. (2009) · Science · doi:10.1126/science.1168683 · Cited by 675
Prognostic value of epidermal growth factor receptor in patients with glioblastoma multiforme.
Shinojima, N., Tada, K., Shiraishi, S., Kamiryo, T., Kochi, M., Nakamura, H., Makino, K., Saya, H., Hirano, H., Kuratsu, J., et al. (2003) · PubMed · Cited by 663
Smith, J. S., Tachibana, I., Passe, S. M., Huntley, B. K., Borell, T. J., Iturria, N., O'Fallon, J. R., Schaefer, P. L., Scheithauer, B. W., James, C. D., et al. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.16.1246 · Cited by 630
Huang, H.-J. S., Nagane, M., Klingbeil, C. K., Lin, H., Nishikawa, R., Ji, X.-D., Huang, C.-M., Gill, G. N., Wiley, H. S., & Cavenee, W. K. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.5.2927 · Cited by 595
Holland, E. C., Hively, W. P., DePinho, R. A., & Varmus, H. E. (1998) · Genes & Development · doi:10.1101/gad.12.23.3675 · Cited by 556
Miao, H., Li, D.-Q., Mukherjee, A., Guo, H., Petty, A., Cutter, J., Basilion, J. P., Sedor, J., Wu, J., Danielpour, D., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.04.009 · Cited by 533
Dittmann, K., Mayer, C., Fehrenbacher, B., Schaller, M., Raju, U., Milas, L., Chen, D. J., Kehlbach, R., & Rodemann, H. P. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506591200 · Cited by 529
Heimberger, A. B., Hlatky, R., Suki, D., Yang, D., Weinberg, J., Gilbert, M., Sawaya, R., & Aldape, K. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1737 · Cited by 516
Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis
Sarkisian, C. J., Keister, B. A., Stairs, D. B., Boxer, R. B., Moody, S. E., & Chodosh, L. A. (2007) · Nature Cell Biology · doi:10.1038/ncb1567 · Cited by 490
EphA2 overexpression causes tumorigenesis of mammary epithelial cells.
Zelinski, D. P., Zantek, N. D., Stewart, J. C., Irizarry, A. R., & Kinch, M. S. (2001) · PubMed · Cited by 463
Prevalence of aberrant expression of the epidermal growth factor receptor in human cancers
Gullick, W. J. (1991) · British Medical Bulletin · doi:10.1093/oxfordjournals.bmb.a072464 · Cited by 449
Role of non-homologous end joining (NHEJ) in maintaining genomic integrity
Burma, S., Chen, B. P. C., & Chen, D. J. (2006) · DNA Repair · doi:10.1016/j.dnarep.2006.05.026 · Cited by 422
Self-citationSchmidt-Ullrich, R. K., Mikkelsen, R. B., Dent, P., Todd, D. G., Valerie, K., Kavanagh, B. D., Contessa, J. N., Rorrer, W. K., & Chen, P. B. (1997) · Oncogene · doi:10.1038/sj.onc.1201275 · Cited by 412
Nagane, M., Coufal, F. J., Lin, H., Bögler, O., Cavenee, W. K., & Huang, H.-J. S. (1996) · PubMed · Cited by 405
PKBα/Akt1 Acts Downstream of DNA-PK in the DNA Double-Strand Break Response and Promotes Survival
Bozulic, L., Surucu, B., Hynx, D., & Hemmings, B. A. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.02.024 · Cited by 386
Molecular Imaging in the Clinical Arena
Jaffer, F. A. (2005) · JAMA · doi:10.1001/jama.293.7.855 · Cited by 369
Nagane, M., Levitzki, A., Gazit, A., Cavenee, W. K., & Huang, H.-J. S. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.10.5724 · Cited by 363
Oncogenic EGFR Signaling Networks in Glioma
Huang, P. H., Xu, A. M., & White, F. M. (2009) · Science Signaling · doi:10.1126/scisignal.287re6 · Cited by 363
Akimoto, T., Hunter, N. R., Buchmiller, L., Mason, K. A., Ang, K. K., & Milas, L. (1999) · PubMed · Cited by 357
Yang, L., Mao, H., Wang, Y. A., Cao, Z., Peng, X., Wang, X., Duan, H., Ni, C., Yuan, Q., Adams, G., et al. (2009) · Small · doi:10.1002/smll.200800714 · Cited by 356
Trafficking of the ErbB receptors and its influence on signaling
Wiley, H. (2003) · Experimental Cell Research · doi:10.1016/s0014-4827(03)00002-8 · Cited by 348
Dent, P., Reardon, D. B., Park, J. S., Bowers, G., Logsdon, C., Valerie, K., & Schmidt-Ullrich, R. (1999) · Molecular Biology of the Cell · doi:10.1091/mbc.10.8.2493 · Cited by 326
Molecular mechanisms underlying endocytosis and sorting of ErbB receptor tyrosine kinases
Waterman, H., & Yarden, Y. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02117-2 · Cited by 314
Batra, S. K., Castelino‐Prabhu, S., Wikstrand, C. J., Zhu, X., Humphrey, P. A., Friedman, H. S., & Bigner, D. D. (1995) · PubMed · Cited by 312
Mutant epidermal growth factor receptor up-regulates molecular effectors of tumor invasion.
Lal, A., Glazer, C. A., Martinson, H. M., Friedman, H. S., Archer, G. E., Sampson, J. H., & Riggins, G. J. (2002) · PubMed · Cited by 311
Bredel, M., Bredel, C., Juric, D., Harsh, G. R., Vogel, H., Recht, L. D., & Sikic, B. I. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1204 · Cited by 311
Moscatello, D. K., Holgado-Madruga, M., Emlet, D. R., Montgomery, R. B., & Wong, A. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.1.200 · Cited by 305
Integration of EGFR inhibitors with radiochemotherapy
Nyati, M. K., Morgan, M. A., Feng, F. Y., & Lawrence, T. S. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1953 · Cited by 304
Near-infrared optical imaging of epidermal growth factor receptor in breast cancer xenografts.
Shi, K., Wen, X., Gurfinkel, M., Charnsangavej, C., Wallace, S., Sevick-Muraca, E. M., & Li, C. (2003) · PubMed · Cited by 293
EphA2 as a Novel Molecular Marker and Target in Glioblastoma Multiforme
Wykosky, J., Gibo, D. M., Stanton, C., & Debinski, W. (2005) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-05-0056 · Cited by 290
Inhibition of radiation-induced EGFR nuclear import by C225 (Cetuximab) suppresses DNA-PK activity
Dittmann, K., Mayer, C., & Rodemann, H.-P. (2005) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2005.06.022 · Cited by 287
Aldape, K. D., Ballman, K., Furth, A., Buckner, J. C., Giannini, C., Burger, P. C., Scheithauer, B. W., Jenkins, R. B., & James, C. D. (2004) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/63.7.700 · Cited by 278
Simmons, M. L., Lamborn, K. R., Takahashi, M., Chen, P.-Y., Israel, M. A., Berger, M. S., Godfrey, T. E., Nigro, J. M., Prados, M. D., Chang, S. M., et al. (2001) · PubMed · Cited by 278
Brown, P. D., Krishnan, S., Sarkaria, J. N., Wu, W., Jaeckle, K. A., Uhm, J. H., Geoffroy, F. J., Arusell, R., Kitange, G., Jenkins, R. B., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.0612 · Cited by 277
Mukherjee, B., McEllin, B., Camacho, C. V., Tomimatsu, N., Sirasanagandala, S., Nannepaga, S., Hatanpaa, K. J., Mickey, B., Madden, C., Maher, E., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4853 · Cited by 270
Self-citation(2003) · PubMed · Cited by 269
Marco, E. D., Pierce, J. H., Fleming, T. P., Kraus, M. H., Molloy, C. J., Aaronson, S. A., & Fiore, P. P. D. (1989) · PubMed · Cited by 266
Sato, M., Vaughan, M. B., Girard, L., Peyton, M., Lee, W., Shames, D. S., Ramirez, R. D., Sunaga, N., Gazdar, A. F., Shay, J. W., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2521 · Cited by 263
Tohma, Y., Gratas, C., Biernat, W., Peraud, A., Fukuda, M., Yonekawa, Y., Kleihues, P., & Ohgaki, H. (1998) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199807000-00005 · Cited by 256
Cai, W., Chen, K., He, L., Cao, Q., Koong, A., & Chen, X. (2007) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-006-0361-6 · Cited by 241
Genetic Profile of Gliosarcomas
Reis, R. M., Könü-Lebleblicioglu, D., Lopes, J. M., Kleihues, P., & Ohgaki, H. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64746-3 · Cited by 235
Heimberger, A. B., Alexander, L. E. C., Archer, G. E., Hess, K. R., Wikstrand, C. J., Friedman, A. H., Friedman, H. S., Bigner, D. D., & Sampson, J. H. (2003) · PubMed · Cited by 234
Wiley, H. S. (1988) · The Journal of cell biology · doi:10.1083/jcb.107.2.801 · Cited by 230
Bandyopadhyay, D., Mandal, M., Adam, L., Mendelsohn, J., & Kumar, R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.3.1568 · Cited by 229
Kao, G. D., Jiang, Z., Fernandes, A. M., Gupta, A. K., & Maity, A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703042200 · Cited by 228
Role of DNA–PK in the cellular response to DNA double-strand breaks
Burma, S., & Chen, D. J. (2004) · DNA Repair · doi:10.1016/j.dnarep.2004.03.021 · Cited by 219
Self-citationDas, A. K., Sato, M., Story, M. D., Peyton, M., Graves, R., Redpath, S., Girard, L., Gazdar, A. F., Shay, J. W., Minna, J. D., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2627 · Cited by 216
Nicholas, M. K., Lukas, R. V., Jafri, N. F., Faoro, L., & Salgia, R. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0874 · Cited by 214
Quantitative analysis of the endocytic system involved in hormone-induced receptor internalization.
Lund, K. A., Opresko, L. K., Starbuck, C., Walsh, B. J., & Wiley, H. S. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)55456-9 · Cited by 210
Transformational and altered signal transduction by a naturally occurring mutant EGF receptor.
Moscatello, D. K., Montgomery, B., Sundareshan, P., McDanel, H. J., Wong, M. Y., & Wong, A. J. (1996) · PubMed · Cited by 207
Golding, S. E., Morgan, R. N., Adams, B. R., Hawkins, A. J., Povirk, L. F., & Valerie, K. (2009) · Cancer Biology & Therapy · doi:10.4161/cbt.8.8.7927 · Cited by 202
Radiation-induced EGFR-signaling and control of DNA-damage repair
Rodemann, H. P., Dittmann, K., & Toulany, M. (2007) · International Journal of Radiation Biology · doi:10.1080/09553000701769970 · Cited by 201
Age-Dependent Prognostic Effects of Genetic Alterations in Glioblastoma
Batchelor, T. T., Betensky, R. A., Esposito, J. M., Pham, L.-D. D., Dorfman, M. V., Piscatelli, N., Jhung, S., Rhee, D., & Louis, D. N. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0841-3 · Cited by 200
Arslan, A. A., Gold, L. I., Mittal, K., Suen, T.-C., Belitskaya-Levy, I., Tang, M.-S., & Toniolo, P. (2005) · Human Reproduction · doi:10.1093/humrep/deh698 · Cited by 195
Collins, C. S., Hong, J., Sapinoso, L., Zhou, Y., Liu, Z., Micklash, K., Schultz, P. G., & Hampton, G. M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600040103 · Cited by 189
Narita, Y., Nagane, M., Mishima, K., Huang, H.-J. S., Furnari, F. B., & Cavenee, W. K. (2002) · PubMed · Cited by 189
Toulany, M., Kehlbach, R., Florczak, U., Sak, A., Wang, S., Chen, J., Lobrich, M., & Rodemann, H. P. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-2200 · Cited by 186
CHU, C. T., EVERISS, K. D., WIKSTRAND, C. J., BATRA, S. K., KUNG, H.-J., & BIGNER, D. D. (1997) · Biochemical Journal · doi:10.1042/bj3240855 · Cited by 184
Miller, C. R., Dunham, C. P., Scheithauer, B. W., & Perry, A. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.1497 · Cited by 178
Prigent, S. A., Nagane, M., Lin, H., Huvar, I., Boss, G. R., Feramisco, J. R., Cavenee, W. K., & Huang, H.-J. S. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.41.25639 · Cited by 175
Learn, C. A., Hartzell, T. L., Wikstrand, C. J., Archer, G. E., Rich, J. N., Friedman, A. H., Friedman, H. S., Bigner, D. D., & Sampson, J. H. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0521 · Cited by 173
p53 stabilization in response to DNA damage requires Akt/PKB and DNA-PK
Boehme, K. A., Kulikov, R., & Blattner, C. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703423105 · Cited by 171
Sung, T., Miller, D. C., Hayes, R. L., Alonso, M., Yee, H., & Newcomb, E. W. (2000) · Brain Pathology · doi:10.1111/j.1750-3639.2000.tb00258.x · Cited by 169
Li, B., Yuan, M., Kim, I.-A., Chang, C.-M., Bernhard, E. J., & Shu, H.-K. G. (2004) · Oncogene · doi:10.1038/sj.onc.1207602 · Cited by 168
Schmidt, M. H. H., Furnari, F. B., Cavenee, W. K., & Bögler, O. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1031790100 · Cited by 164
de la Iglesia, N., Konopka, G., Lim, K.-L., Nutt, C. L., Bromberg, J. F., Frank, D. A., Mischel, P. S., Louis, D. N., & Bonni, A. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.5385-07.2008 · Cited by 163
Potential indicators of radiosensitivity in squamous cell carcinoma of the head and neck
Sheridan, M. T., O’Dwyer, T. P., Seymour, C. B., & Mothersill, C. E. (1997) · Radiation Oncology Investigations · doi:10.1002/(sici)1520-6823(1997)5:4<180::aid-roi3>3.0.co;2-u · Cited by 162
Epidermal growth factor receptor and tumor response to radiation: in vivo preclinical studies
Milas, L., Fan, Z., Andratschke, N. H., & Ang, K. K. (2004) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2003.08.035 · Cited by 162
Das, A. K., Chen, B. P., Story, M. D., Sato, M., Minna, J. D., Chen, D. J., & Nirodi, C. S. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0242 · Cited by 160
Wen, X.-F., Yang, G., Mao, W., Thornton, A., Liu, J., Bast, R. C., & Le, X.-F. (2006) · Oncogene · doi:10.1038/sj.onc.1209685 · Cited by 159
Contessa, J. N., Hampton, J. L., Lammering, G., Mikkelsen, R. B., Dent, P., Valerie, K. C., & Schmidt‐Ullrich, R. (2002) · Oncogene · doi:10.1038/sj.onc.1205500 · Cited by 153
Edwards, E., Geng, L., Tan, J., Onishko, H. M., Donnelly, E. F., & Hallahan, D. E. (2002) · PubMed · Cited by 152
Predominant Expression of Mutant EGFR (EGFRvIII) is Rare in Primary Glioblastomas
Biernat, W., Huang, H., Yokoo, H., Kleihues, P., & Ohgaki, H. (2004) · Brain Pathology · doi:10.1111/j.1750-3639.2004.tb00045.x · Cited by 152
Effect of common B-RAF and N-RAS mutations on global gene expression in melanoma cell lines
Bloethner, S., Chen, B., Hemminki, K., Müller‐Berghaus, J., Ugurel, S., Schadendorf, D., & Kumar, R. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi066 · Cited by 151
Balaban, N., Moni, J., Shannon, M., Dang, L. B., Murphy, E., & Goldkorn, T. (1996) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(96)00068-7 · Cited by 150
Perry, A., Aldape, K., George, D. H., & Burger, P. C. (2004) · Cancer · doi:10.1002/cncr.20625 · Cited by 148
Glioblastomas with an Oligodendroglial Component: A Pathological and Molecular Study
He, J., Mokhtari, K., Sanson, M., et al. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.9.863 · Cited by 142
The autocrine loop of TGF-α/EGFR and brain tumors
Tang, P., Steck, P. A., & Yung, W. K. A. (1997) · Journal of Neuro-Oncology · doi:10.1023/a:1005824802617 · Cited by 140
Endocytosis and mitogenic signaling
Fiore, P. P. D., & Gillt, G. N. (1999) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(99)80069-6 · Cited by 140
Ramnarain, D. B., Park, S., Lee, D. Y., Hatanpaa, K. J., Scoggin, S. O., Otu, H., Libermann, T. A., Raisanen, J. M., Ashfaq, R., Wong, E. T., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2753 · Cited by 140
Self-citationVelikyan, I., Sundberg, Å. L., Lindhe, Ö., Höglund, A. U., Eriksson, O., Werner, E., Carlsson, J., Bergström, M., Långström, B., & Максимилианович, Т. В. (2005) · PubMed · Cited by 134
Karpel‐Massler, G., Schmidt, U. I., Unterberg, A. W., & Halatsch, M. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0479 · Cited by 133
Cerniglia, G. J., Pore, N., Tsai, J. H., Schultz, S. M., Mick, R., Choe, R., Xing, X., Durduran, T., Yodh, A. G., Evans, S. M., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006539 · Cited by 132
Wright, J. H., Wang, X., Manning, G., LaMere, B. J., Le, P., Zhu, S., Khatry, D., Flanagan, P. M., Buckley, S. D., Whyte, D. B., et al. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.6.2068-2082.2003 · Cited by 126
Okada, Y., Hurwitz, E. E., Esposito, J. M., et al. (2003) · PubMed · Cited by 118
Small Cell Architecture—A Histological Equivalent of EGFR Amplification in Glioblastoma Multiforme?
Burger, P. C., Pearl, D. K., Aldape, K., Yates, A. J., Scheithauer, B. W., Passe, S. M., Jenkins, R. B., & James, C. D. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.11.1099 · Cited by 117
Constitutive EGFR signaling confers a motile phenotype to neural stem cells
Boockvar, J. A., Kapitonov, D., Kapoor, G. S., Schouten, J. W., Counelis, G. J., Bögler, O., Snyder, E. Y., McIntosh, T. K., & O’Rourke, D. M. (2003) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2003.09.011 · Cited by 115
Максимилианович, Т. В., Friedman, M., Sandström, M., Eriksson, T. L. J., Rosik, D., Hodik, M., Ståhl, S., Frejd, F. Y., & Orlova, A. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.055525 · Cited by 115
Liu, F., Park, P. J., Lai, W. R., Maher, E. A., Chakravarti, A., Durso, L. E., Jiang, X., Yu, Y., Brosius, A., Thomas, M. M., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1408 · Cited by 115
Pal, A., Glekas, A., Doubrovin, M., Balatoni, J., Beresten, T., Maxwell, D. S., Soghomonyan, S., Shavrin, A., Ageyeva, L., Finn, R., et al. (2006) · Molecular Imaging and Biology · doi:10.1007/s11307-006-0049-0 · Cited by 111
Pediatric glioblastomas: A histopathological and molecular genetic study
Suri, V. S., Das, P., Jain, A., Sharma, M. C., Borkar, S. A., Suri, A., Gupta, D. K., & Sarkar, C. (2008) · Neuro-Oncology · doi:10.1215/15228517-2008-092 · Cited by 110
Giant cell glioblastoma: A glioblastoma subtype with distinct epidemiology and superior prognosis
Kozak, K. R., & Moody, J. S. (2009) · Neuro-Oncology · doi:10.1215/15228517-2008-123 · Cited by 110
Multimodality imaging of the HER-kinase axis in cancer
Cai, W., Niu, G., & Chen, X. S. (2007) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-007-0560-9 · Cited by 108
Elevated JNK activation contributes to the pathogenesis of human brain tumors
Antonyak, M. A., Kenyon, L. C., Godwin, A. K., James, D. C., Emlet, D. R., Okamoto, I., Tnani, M., Holgado-Madruga, M., Moscatello, D. K., & Wong, A. J. (2002) · Oncogene · doi:10.1038/sj.onc.1205593 · Cited by 106
Friedmann, B. J., Caplin, M. E., Savic, B., Shah, T., Lord, C. J., Ashworth, A., Hartley, J. A., & Hochhauser, D. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0239 · Cited by 103
Aghi, M. K., Gaviani, P., Henson, J. W., Batchelor, T. T., Louis, D. N., & Barker, F. G. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0713 · Cited by 103
Mishima, K., Higashiyama, S., Asai, A., Yamaoka, K., Nagashima, Y., Taniguchi, N., Kitanaka, C., Kirino, T., & Kuchino, Y. (1998) · Acta Neuropathologica · doi:10.1007/s004010050901 · Cited by 99
Fos-Related Antigen 1 Modulates Malignant Features of Glioma Cells
Debinski, W., & Gibo, D. M. (2005) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-05-0004 · Cited by 92
Suwa, T., Ozawa, S., Ueda, M., Ando, N., & Kitajima, M. (1998) · International Journal of Cancer · Cited by 88
Regulators of G-Protein Signaling 3 and 4 (RGS3, RGS4) Are Associated with Glioma Cell Motility
Tatenhorst, L., Senner, V., Püttmann, S., & Paulus, W. (2004) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/63.3.210 · Cited by 87
EGFRvIII-mediated radioresistance through a strong cytoprotective response
Lammering, G., Hewit, T. H., Valerie, K. C., et al. (2003) · Oncogene · doi:10.1038/sj.onc.1206788 · Cited by 82
Friedmann, B. J., Caplin, M. E., Hartley, J. A., & Hochhauser, D. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0586 · Cited by 79
Micallef, J., Taccone, M. S., Mukherjee, J., Croul, S. E., Caldwell-Busby, J., Moran, M. F., & Guha, A. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4783 · Cited by 76
Imaging of EGFR and EGFR Tyrosine Kinase Overexpression in Tumors by Nuclear Medicine Modalities
Mishani, E., Abourbeh, G., Eiblmaier, M., & Anderson, C. J. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208786404326 · Cited by 76
Hama, Y., Urano, Y., Koyama, Y., Choyke, P. L., & Kobayashi, H. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3794 · Cited by 61
Liu, N., Li, M., Li, X., Meng, X., Yang, G., Zhao, S., Yang, Y., Ma, L., Fu, Z., & Yu, J. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.056556 · Cited by 59
Zhan, Y., & O’Rourke, D. M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3143 · Cited by 55
Halatsch, M., Low, S. H. H., Mursch, K., Hielscher, T., Schmidt, U. I., Unterberg, A. W., Vougioukas, V. I., & Feuerhake, F. (2009) · Journal of neurosurgery · doi:10.3171/2008.9.jns08551 · Cited by 52
Glioblastoma Multiforme and the Epidermal Growth Factor Receptor
Friedman, H. S., & Bigner, D. D. (2005) · New England Journal of Medicine · doi:10.1056/nejmp058186 · Cited by 47
Pantaleo, M. A., Nannini, M., Maleddu, A., Fanti, S., Nanni, C., Boschi, S., Lodi, F., Nicoletti, G., Landuzzi, L., Lollini, P., et al. (2008) · Annals of Oncology · doi:10.1093/annonc/mdn625 · Cited by 46
Warmka, J. K., Mauro, L. J., & Wattenberg, E. V. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403120200 · Cited by 45
Second Messenger Systems in Human Gliomas
McLendon, R. E., Turner, K. C., Perkinson, K. R., & Rich, J. N. (2007) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2007-131-1585-smsihg · Cited by 42
Habib, A. A., Chun, S. J., Neel, B. G., & Vartanian, T. K. (2003) · PubMed · Cited by 42
Self-citationActivation of extracellular-regulated kinases by normal and mutant EGF receptors
Lorimer, I. A. J., & Lavictoire, S. J. (2001) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(00)00129-4 · Cited by 41
Filmus, J., Shi, W., & Spencer, T. E. (1993) · PubMed · Cited by 41
Immunohistochemical Markers for Prognosis of Cerebral Glioblastomas
Korshunov, A., Голанов, А. В., & Sycheva, R. (2002) · Journal of Neuro-Oncology · doi:10.1023/a:1016218117251 · Cited by 33
EGFR mutations and molecularly targeted therapy: a new era in the treatment of lung cancer
Dowell, J. E., & Minna, J. D. (2006) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0476 · Cited by 21
Improving resection of malignant glioma
Barker, F. G., & Chang, S. M. (2006) · The Lancet Oncology · doi:10.1016/s1470-2045(06)70669-6 · Cited by 20
PIKK-ing a New Partner: A New Role for PKB in the DNA Damage Response
Lees‐Miller, S. P. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.04.010 · Cited by 13
Cited by
Epidemiologic and Molecular Prognostic Review of Glioblastoma
Thakkar, J. P., Dolecek, T. A., Horbinski, C., Ostrom, Q. T., Lightner, D. D., Barnholtz-Sloan, J. S., & Villano, J. L. (2014) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-14-0275 · Cited by 1,390
The ErbB/HER family of protein-tyrosine kinases and cancer
Roskoski, R. (2014) · Pharmacological Research · doi:10.1016/j.phrs.2013.11.002 · Cited by 1,353
Exosomes from marrow stromal cells expressing miR-146b inhibit glioma growth
Katakowski, M., Buller, B., Zheng, X., Lu, Y., Rogers, T., Osobamiro, O., Shu, W., Jiang, F., & Chopp, M. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.02.019 · Cited by 681
mTOR: Role in cancer, metastasis and drug resistance
Murugan, A. K. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.07.003 · Cited by 483
Johnson, L. A., Scholler, J., Ohkuri, T., Kosaka, A., Patel, P. R., McGettigan, S. E., Nace, A. K., Dentchev, T., Thekkat, P., Loew, A., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa4963 · Cited by 454
Metadata
- Authors
- Hatanpaa, K. J., Burma, S., Zhao, D., & Habib, A. A.
- Venue
- Neoplasia
- Publisher
- Elsevier BV
- Published
- 2010-09
- Volume
- 12
- Issue
- 9
- Pages
- 675-684
- ISSN
- 1476-5586 (ISSN-L)
- OpenAlex
- W2103744931
- Cited by
- 471
- References
- 140
- FWCI
- 12.83
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.